Innovative Compounding Pharmacy
FDA inspection history in Folsom, California, 2015 to 2016
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2015: one Form 483; 2016: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2015–16One Form 483 and one warning letter, at Folsom, California.
Cited most
Across all Innovative Compounding Pharmacy observations on file
- 21 CFR 211.42(c)Design and construction features4
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.165(a)Testing and release for distribution1
- 21 CFR 211.166(a)Stability testing1
- 21 CFR 211.167(a)Special testing requirements1
The complete Innovative Compounding Pharmacy file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Folsom, California
One warning letter and one Form 483 · 2015 to 2016 · 10 observations
Latest: Warning letter, Jun 20, 2016 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2016-06-20 | Warning letter Warning letter | Folsom, California | — | $99 |
| 2015-04-17 | 483 Form 483 | Folsom, California | 10 | $99 |
Investigators on these documents
FEI number 3011396023 · most recent document Jun 20, 2016
About Innovative Compounding Pharmacy
How many FDA Form 483s has Innovative Compounding Pharmacy received?
FDA Intel has 1 Form 483 on file for Innovative Compounding Pharmacy; the most recent is dated Apr 17, 2015.
When was Innovative Compounding Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for Innovative Compounding Pharmacy is a Form 483 dated Apr 17, 2015, for the site in Folsom, California.
What did FDA cite at Innovative Compounding Pharmacy?
The regulations cited most in the observations on file for Innovative Compounding Pharmacy are 21 CFR 211.42(c) (Design and construction features), 4 times; 21 CFR 211.113(b) (Control of microbiological contamination), 1 time; 21 CFR 211.165(a) (Testing and release for distribution), 1 time.
Has Innovative Compounding Pharmacy received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Innovative Compounding Pharmacy; the most recent is dated Jun 20, 2016.